Evotec is a leader in the discovery and development of novel small molecule drugs with operational sites in Europe and the US. The Company has built substantial drug discovery expertise and an industrialised platform that can drive new innovative small molecule compounds into the clinic. In addition, Evotec has built a deep internal knowledge base in the treatment of diseases related to neuroscience, pain, oncology, inflammation and metabolic diseases.
Amsbio has launched a new range of authenticated cell lines covering a wide range of tumours, tissues, and species. With this addition of greater than 1000 independently verified human and animal cell lines, versatile primary and stem cells, the expanded range of top quality, cell lines from Amsbio are second to none.
What if the work you did every day could impact the lives of people you know? Or all of humanity?
At Illumina, we are expanding access to genomic technology to realize health equity for billions of people around the world. Our efforts enable life-changing discoveries that are transforming human health through the early detection and diagnosis of diseases and new treatment options for patients.
Burlingame CA – 20 May 2026 – Download Press Release
Collaborative Drug Discovery (CDD), the leading provider of data management solutions for the pharmaceutical and biotechnology industries, today announced an agreement with Eli Lilly and Company (Lilly) to integrate Lilly TuneLab, a collaborative AI/ML drug discovery platform, into CDD Vault.
About the role
We are seeking an experienced, highly motivated Manager to lead all aspects of the Chemical Biology facility including operational, financial and strategic planning. Your specialist expertise will deliver a world-class service to both internal, external users and commercial partners. You will manage and allocate tasks to technical staff within remit and support other departmental managers, providing appropriate cover during annual leave, sickness, commensurate with the grade.
What you would be doing
Welcome to the Q2 Edition of Our People Pathways Newsletter!
Cambridge Enterprise sits at the heart of one of the world’s leading research ecosystems. As part of the University of Cambridge, we turn academic innovation into real-world impact through licensing, partnerships, spinouts and investment.
We support academics, researchers, staff and students in translating their ideas into practice, helping innovators, experts and entrepreneurs use commercial pathways to develop their work for the benefit of society, the economy, themselves and the University.
TTP is an employee-owned technology and product development consultancy, with a 40-year track record of partnering with ambitious clients to solve complex challenges and bring innovative, commercially successful solutions to market.
We invent, design, and manufacture impactful products and technologies across a wide range of industries – including healthcare, life science, energy, and communications – and at the intersection of engineering, physical science, and biology.
The UK Health Security Agency (UKHSA) prevents, prepares for and responds to infectious diseases, and environmental hazards, to keep all our communities safe, save lives and protect livelihoods.
We provide scientific and operational leadership, working with local, national and international partners to protect the public’s health and build the nation’s health security capability.
BURLINGAME, Calif., May 20, 2026 /PRNewswire/ -- Collaborative Drug Discovery (CDD), the leading provider of data management solutions for the pharmaceutical and biotechnology industries, today announced an agreement with Eli Lilly and Company (Lilly) to integrate Lilly TuneLab, a collaborative AI/ML drug discovery platform, into CDD Vault.